Trading
Please use a PC Browser to access Register-Tadawul
Morgan Stanley Initiates Coverage On AgomAb Therapeutics with Overweight Rating, Announces Price Target of $28
Share
AgomAb Therapeutics NV ADR
AGMB
14.21
-3.20%